Abstract
Gabapentin is an important advancement for the treatment of neuropathic pain. This novel anticonvulsant has demonstrated efficacy and safety in multiple clinical trials. Its pharmacological properties especially lack of adverse effects on any major organ systems including cardiovascular and respiratory systems allows flexible titration in a wide range of patients. Certainly, there are many side effects but majority are manageable and all of them are reversible.
Keywords: neuropathic pain, gabapentin, dosing schedule, adverse events, side effects, efficacy
Current Neuropharmacology
Title: Symptomatic Treatment of Chronic Neuropathic Pain with Gabapentin Clinical Practice and Research Prospective
Volume: 1 Issue: 3
Author(s): Misha-Miroslav Backonja
Affiliation:
Keywords: neuropathic pain, gabapentin, dosing schedule, adverse events, side effects, efficacy
Abstract: Gabapentin is an important advancement for the treatment of neuropathic pain. This novel anticonvulsant has demonstrated efficacy and safety in multiple clinical trials. Its pharmacological properties especially lack of adverse effects on any major organ systems including cardiovascular and respiratory systems allows flexible titration in a wide range of patients. Certainly, there are many side effects but majority are manageable and all of them are reversible.
Export Options
About this article
Cite this article as:
Backonja Misha-Miroslav, Symptomatic Treatment of Chronic Neuropathic Pain with Gabapentin Clinical Practice and Research Prospective, Current Neuropharmacology 2003; 1 (3) . https://dx.doi.org/10.2174/1570159033477062
DOI https://dx.doi.org/10.2174/1570159033477062 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Pharmacogenetic Approach to Treating Drug Dependence: Serotonin Transporter Gene (SLC6A4) Promoter Polymorphisms as Treatment Predictors in Jordanian Arabs
Current Pharmacogenomics and Personalized Medicine Melatonin in the Biliary Tract and Liver: Health Implications
Current Pharmaceutical Design Small Interfering RNAs and Antisense Oligonucleotides for Treatment of Neurological Diseases
Current Drug Targets Preface: Vitamin D and QT Interval in Epilepsy: More than an Association?
Current Clinical Pharmacology Addressing Alzheimer’s Disease and Cognitive Loss through Autophagy
Current Neurovascular Research A Comprehensive Review on Preclinical Evidence-based Neuroprotective Potential of <i>Bacopa monnieri</i> against Parkinson's Disease
Current Drug Targets Bacterial Protein Toxins: Current and Potential Clinical Use
Current Medicinal Chemistry Nanotechnological Advances in the Treatment of Epilepsy
CNS & Neurological Disorders - Drug Targets Targeting S100B Protein as a Surrogate Biomarker and its Role in Various Neurological Disorders
Current Neuropharmacology Design, Characterization and Evaluation of Anti-epileptic Activity of Nanoprecipitating Preconcentrate of Carbamazepine
Drug Delivery Letters Changes in Bone Turnover, Bone Mineral and Fracture Risk Induced by Drugs Used to Treat Epilepsy
Current Drug Safety Screening the Receptorome Yields Validated Molecular Targets for Drug Discovery
Current Pharmaceutical Design Perspectives on Brain-Targeting Drug Delivery Systems
Current Pharmaceutical Biotechnology Molecular Docking, Synthesis and CNS Activity of Some Novel 1, 4-Benzodiazepine Derivatives
Letters in Drug Design & Discovery Understanding Membrane Protein Drug Targets in Computational Perspective
Current Drug Targets Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer’s Disease
Current Alzheimer Research α7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson’s Disease
Current Drug Targets Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens
Recent Patents on Biotechnology Mitochondrial Respiratory Complex I: Structure, Function and Implication in Human Diseases
Current Medicinal Chemistry Development and Evaluation of an Anti-Epileptic Oral Fast-Dissolving Film with Enhanced Dissolution and In vivo Permeation
Current Drug Delivery